Tangier disease

Tangier disease
ICD-10	E78.6
ICD-9	272.5
OMIM	205400
DiseasesDB	12901
MeSH	D013631

WikiDoc Resources for Tangier disease
Articles
Most recent articles on Tangier disease Most cited articles on Tangier disease Review articles on Tangier disease Articles on Tangier disease in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tangier disease Images of Tangier disease Photos of Tangier disease Podcasts & MP3s on Tangier disease Videos on Tangier disease
Evidence Based Medicine
Cochrane Collaboration on Tangier disease Bandolier on Tangier disease TRIP on Tangier disease
Clinical Trials
Ongoing Trials on Tangier disease at Clinical Trials.gov Trial results on Tangier disease Clinical Trials on Tangier disease at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tangier disease NICE Guidance on Tangier disease NHS PRODIGY Guidance FDA on Tangier disease CDC on Tangier disease
Books
Books on Tangier disease
News
Tangier disease in the news Be alerted to news on Tangier disease News trends on Tangier disease
Commentary
Blogs on Tangier disease
Definitions
Definitions of Tangier disease
Patient Resources / Community
Patient resources on Tangier disease Discussion groups on Tangier disease Patient Handouts on Tangier disease Directions to Hospitals Treating Tangier disease Risk calculators and risk factors for Tangier disease
Healthcare Provider Resources
Symptoms of Tangier disease Causes & Risk Factors for Tangier disease Diagnostic studies for Tangier disease Treatment of Tangier disease
Continuing Medical Education (CME)
CME Programs on Tangier disease
International
Tangier disease en Espanol Tangier disease en Francais
Business
Tangier disease in the Marketplace Patents on Tangier disease
Experimental / Informatics
List of terms related to Tangier disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Tangier disease is a rare inherited disorder characterized by a severe reduction in the amount of high density lipoprotein (HDL), often referred to as "good cholesterol," in the bloodstream.

Diagnosis

High-density lipoproteins are created when a protein in the bloodstream, apolipoprotein A1 (apoA1), combines with cholesterol and phospholipids. The cholesterol and phospholipids used to form HDL originate from inside cells but is transported out of the cell into the blood via the ABCA1 transporter. People with Tangier disease have defective ABCA1 transporters resulting in a greatly reduced ability to transport cholesterol out of their cells, which leads to an accumulation of cholesterol in many body tissues. Reduced blood levels of high-density lipoproteins is sometimes described as hypoalphalipoproteinemia.

People affected by this condition also have slightly elevated amounts of fat in the blood (mild hypertriglyceridemia) and disturbances in nerve function (neuropathy). The tonsils are visibly affected by this disorder; they frequently appear orange or yellow and are extremely enlarged. Affected people often develop premature atherosclerosis, which is characterized by fatty deposits and scar-like tissue lining the arteries. Other signs of this condition may include an enlarged spleen (splenomegaly), an enlarged liver (hepatomegaly), clouding of the cornea, and early-onset cardiovascular disease.

Tangier disease is a rare disorder with approximately 50 cases identified worldwide. This disorder was originally discovered on Tangier Island off the coast of Virginia, but has now been identified in people from many different countries.

Genetics

File:Autorecessive.svg Mutations to chromosome 9q31 lead to a defective ABCA1 transporter.

These mutations prevent the ABCA1 protein from effectively transporting cholesterol and phospholipids out of cells for pickup by ApoA1 in the bloodstream.

This inability to transport cholesterol out of cells leads to a deficiency of high-density lipoproteins in the circulation, which is a risk factor for coronary artery disease.

Additionally, the buildup of cholesterol in cells can be toxic, causing cell death or impaired function. These combined factors lead to the signs and symptoms of Tangier disease.

This condition is inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered.

Most often, the parents of an individual with an autosomal recessive disorder are carriers of one copy of the altered gene but do not show signs and symptoms of the disorder.

External links

• Tangier disease at NLM Genetics Home Reference